A 52-year-old man with newly diagnosed acute myeloid leukemia (AML) undergoes chemotherapy with cytarabine. A bone marrow aspirate is obtained 48 hours post-treatment to assess treatment response. Which investigation is most appropriate to confirm that leukemic blasts are undergoing apoptosis rather than necrosis?

Explanation

## Investigation of Choice for Apoptosis Detection **Key Point:** Annexin V–propidium iodide (PI) flow cytometry is the gold standard for distinguishing apoptosis from necrosis in clinical and research settings. ### Why Annexin V–PI Flow Cytometry? **High-Yield:** The combination detects: - **Annexin V+/PI−** = Early apoptosis (phosphatidylserine externalization on intact membrane) - **Annexin V+/PI+** = Late apoptosis (membrane permeabilization) - **Annexin V−/PI+** = Necrosis (primary membrane loss without PS exposure) **Clinical Pearl:** This is the standard method used in oncology to assess chemotherapy-induced apoptosis in leukemic blasts and is widely available in flow cytometry labs. ### Why Other Options Are Inferior | Investigation | Limitation | |---|---| | **Electron microscopy** | Requires specialized expertise, time-consuming, not routinely available; cannot quantify apoptotic cells efficiently | | **Serum LDH** | Non-specific marker of cell death; elevated in both apoptosis and necrosis; reflects tumor burden, not mechanism | | **H&E biopsy** | Morphology shows apoptotic bodies but cannot reliably distinguish early apoptosis from necrosis; not quantitative | **Mnemonic:** **FACS** (Fluorescence-Activated Cell Sorting) with **AV-PI** = **Apoptosis Validation** — the fastest, most specific, and most quantitative method. [cite:Robbins 10e Ch 7]